Marie Skłodowska-Curie Actions
Overview
Marie Skłodowska-Curie Actions (MSCA) is the European Union's flagship funding programme for doctoral education and postdoctoral training, supporting researchers at all stages of their careers across all disciplines.
Year Founded
1996
Portfolio Companies
4
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Iceni Glycoscience | Mar 2021 | Grant | Co-investor |
| Bionnov | - | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Marie Skłodowska-Curie Actions based?
Marie Skłodowska-Curie Actions is headquartered in Brussels, Belgium.
When was Marie Skłodowska-Curie Actions founded?
Marie Skłodowska-Curie Actions was founded in 1996.
How many portfolio companies does Marie Skłodowska-Curie Actions have?
Marie Skłodowska-Curie Actions has 4 portfolio companies in Caplight's dataset.
What are some companies in Marie Skłodowska-Curie Actions's portfolio?
Portfolio companies visible on Caplight include Iceni Glycoscience, Bionnov.
What was Marie Skłodowska-Curie Actions's most recent investment shown here?
Marie Skłodowska-Curie Actions's most recent investment in this portfolio sample was in Iceni Glycoscience in 2021.
What sectors does Marie Skłodowska-Curie Actions focus on?
Marie Skłodowska-Curie Actions focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does Marie Skłodowska-Curie Actions focus on?
Stage focus information for Marie Skłodowska-Curie Actions is not publicly available.
What is Marie Skłodowska-Curie Actions's AUM?
Marie Skłodowska-Curie Actions's assets under management are estimated between $7.1B and $7.1B.